Over 15% of all world functionality centre (GCC) staff in India are concerned within the healthcare and life sciences sector, reflecting the sector’s rising significance inside the nation’s world providers panorama, in line with latest studies.
Furthermore, a big share—over 55%—of those GCCs are backed by US-headquartered corporations, underlining the sector’s robust worldwide roots.
Geographically, round 85% of healthcare and Life Sciences GCCs are concentrated in 4 main hubs: Bengaluru, Hyderabad, Mumbai, and Delhi-NCR. Bengaluru leads with almost 33% of the full centres, adopted carefully by Hyderabad and Mumbai.
Notably, round 20% of those centres have expanded their footprint throughout three or extra cities, signalling a development in the direction of multi-city operations. Hyderabad, particularly, has not too long ago emerged as a rising star on this sector, pushed by engaging authorities incentives, trendy infrastructure, and a wealthy expertise pool.
A few of the prime corporations primarily based on GCCs headcount in India are Novartis, Pfizer, Abbott, Siemens Healthineers, and Eli Lilly.
AIM is internet hosting essentially the most highly effective GCC occasion, MachineCon GCC Summit 2025, from June 20 to 22, 2025, on the ITC Grand in Goa.
Novartis
Over the previous 20 years, Novartis’ improvement hub in India has grown considerably, now working three superior centres throughout two main cities. In Hyderabad, the corporate has a robust presence at each the Novartis Company Centre and Genome Valley, whereas a more recent centre has been established in Mumbai. These centres play a key function in supporting the event of breakthrough medicines throughout a variety of remedy areas, together with cardiovascular, oncology, immunology, neurology, and world well being.
The India hub helps a number of world features similar to world medical operations, technical R&D, affected person security and pharmacovigilance, regulatory affairs, and superior quantitative sciences, amongst others. For over 12 years, Novartis has steadily expanded its technical R&D operations in Genome Valley. Immediately, greater than 350 extremely certified scientists—together with grasp’s, PhDs, and post-doctorates—are actively contributing to the pharmaceutical improvement of latest chemical entities.
With a staff of round 2,400 staff throughout its improvement division in India, this hub performs an important function in driving Novartis’ long-term development and advancing its mission to enhance and prolong folks’s lives.
Pfizer
Over the a long time, Pfizer has launched a lot of its world, breakthrough therapies throughout main therapeutic areas whereas additionally constructing one in all India’s most recognised native model portfolios, benefiting thousands and thousands of sufferers and customers.
Pfizer operates in India by means of three authorized entities: Pfizer Restricted, Pfizer Merchandise India Non-public Ltd, and Pfizer Healthcare India Non-public Restricted.
Throughout these entities, greater than 5,500 colleagues are engaged in business operations, world manufacturing, R&D, and different features—all united in Pfizer’s mission to stop, deal with, and remedy a number of the most urgent well being challenges going through India and the world.
Pfizer’s footprint in India contains three manufacturing vegetation, two R&D centres, and 6 regional hubs for business operations and world help features.
Pfizer Healthcare operates a world-class sterile injectables manufacturing facility in Visakhapatnam, Andhra Pradesh—one in all Pfizer’s largest of its type globally. This plant provides essential medicines to over 30 international locations.
In Chennai, Pfizer Healthcare additionally runs a state-of-the-art R&D centre targeted on small molecules. The centre employs prime scientific expertise and performs a key function in world analysis, improvement, and technical help for the business manufacturing of parenteral merchandise.
Abbott
Established in 1910, Abbott India is a publicly listed firm and a subsidiary of Abbott Laboratories. Headquartered in Mumbai, the corporate has a workforce of over 14,000 and deep-rooted native experience. It’s dedicated to assembly the healthcare wants of customers, sufferers, healthcare professionals, hospitals, blood banks, and laboratories throughout city and rural India.
As a market chief in prescribed drugs, vitamin, medical gadgets, and diagnostics, Abbott affords a broad and trusted portfolio. This contains greater than 400 pharmaceutical manufacturers, a variety of dietary merchandise tailor-made for infants, kids, energetic adults, and people with particular dietary wants, and superior medical gadgets similar to blood glucose screens and vascular options. As well as, Abbott gives complete diagnostic instruments that help well timed and correct healthcare supply.
Siemens Healthineers
The Growth Centre at Siemens Healthineers in India features as a microcosm of the worldwide organisation, full with an intensive laboratory setup. The corporate takes satisfaction in the truth that almost each product or answer it delivers has roots in India, with the Growth Centre enjoying a central function in its creation and sustaining full possession of the event course of.
In key areas similar to CT, MRI, and molecular imaging, the India staff contributes considerably to each scanner improvement and post-processing applied sciences. Furthermore, the staff performs an important function in synthetic intelligence initiatives, dealing with important duties similar to knowledge mining, annotation, and different associated actions.
Siemens Healthineers has a long-standing manufacturing presence in India, producing medical gadgets for over 60 years. As a part of its continued dedication to innovation and development, the corporate is investing €160 million (roughly ₹1,300 crore) in increasing its Growth Centre in Bengaluru, which is scheduled to open this yr.
With a workforce of round 7,000 staff in India, Siemens Healthineers credit this staff with having a profound influence on its world innovation pipeline—a lot in order that right now, each product from Siemens Healthineers is claimed to have “India inside”.
Eli Lilly
Eli Lilly and Firm established the Lilly Functionality Centre India (LCCI) in 2016 as a cross-functional hub designed to harness the facility of knowledge, content material, analytics, and expertise. Situated in Bengaluru, the centre serves as a strategic accomplice to help Lilly’s world operations and drive innovation.
Presently using 3,372 folks in India, Eli Lilly is increasing its presence with the launch of a second functionality centre in Hyderabad. The brand new facility, additionally named Lilly Functionality Centre India (LCCI) Hyderabad, will concentrate on cutting-edge areas similar to automation, synthetic intelligence, software program engineering, and cloud computing.
The Hyderabad centre is being developed to strengthen Lilly’s world capabilities by enhancing effectivity and accelerating the event of next-generation medicines by means of superior applied sciences and data-driven insights. Recruitment for the brand new centre is already underway, with plans to onboard between 1,000 and 1,500 professionals, together with expertise engineers and knowledge scientists.
The publish 5 GCCs Driving Pharma and Healthcare Innovation appeared first on Analytics India Journal.
